The Sirt1 activator SRT1720 attenuates angiotensin II-induced atherosclerosis in apoE-/- mice through inhibiting vascular inflammatory response

Biochemical and Biophysical Research Communications

Volumn 465, Issue 4, 2015, Pages 732-738

  Chen, Yi Xi ^a   Zhang, Man ^a   Cai, Yuehua ^a   Zhao, Qihui ^a   Dai, Wenjian ^a  

^a Hunan Environment Biological Polytechnic College   (China)

Author keywords

Angiotensin II; Atherosclerosis; NF B; SIRT1; SRT1720; STAT3

Indexed keywords

ANGIOTENSIN II; CHOLESTEROL; FATTY ACID; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; N [2 [3 (1 PIPERAZINYLMETHYL)IMIDAZO[2,1 B]THIAZOL 6 YL]PHENYL] 2 QUINOXALINECARBOXAMIDE; SIRTUIN 1; STAT3 PROTEIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; APOLIPOPROTEIN E; AUTACOID; FUSED HETEROCYCLIC RINGS; MESSENGER RNA; SIRT1 PROTEIN, MOUSE; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; IN VITRO STUDY; MACROPHAGE; MALE; METABOLIC PARAMETERS; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; ANTAGONISTS AND INHIBITORS; DEFICIENCY; DRUG EFFECTS; GENETICS; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SMOOTH MUSCLE CELL;

ANGIOTENSIN II; ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; HETEROCYCLIC COMPOUNDS WITH 4 OR MORE RINGS; INFLAMMATION MEDIATORS; MACROPHAGES; MALE; MICE; MICE, KNOCKOUT; MYOCYTES, SMOOTH MUSCLE; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SIRTUIN 1;

EID: 84941317461     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.08.066     Document Type: Article

References (29)

1. O. López-Franco, P. Hernández-Vargas, G. Ortiz-Muñoz, and et al. Parthenolide modulates the NF-kappaB-mediated inflammatory responses in experimental atherosclerosis Arterioscler. Thromb. Vasc. Biol. 26 2006 1864 1870
2. G. Ortiz-Muñoz, J.L. Martin-Ventura, P. Hernandez-Vargas, and et al. Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis Arterioscler. Thromb. Vasc. Biol. 29 2009 525 531
3. M.C. Haigis, and L.P. Guarente Mammalian sirtuins-emerging roles in physiology, aging, and calorie restriction Genes Dev. 20 2006 2913 2921
4. Q.J. Zhang, Z. Wang, H.Z. Chen, S. Zhou, W. Zheng, G. Liu, and et al. Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice Cardiovasc. Res. 80 2008 191 199
5. S. Stein, C. Lohmann, N. Schafer, J. Hofmann, L. Rohrer, C. Besler, and et al. SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis Eur. Heart J. 31 2010 2301 2309
6. I. Gorenne, S. Kumar, K. Gray, N. Figg, H. Yu, J. Mercer, and et al. Vascular smooth muscle cell sirtuin 1 protects against DNA damage and inhibits atherosclerosis Circulation 127 2013 386 396
7. H.T.1 Zeng, Y.C. Fu, W. Yu, J.M. Lin, L. Zhou, L. Liu, and et al. SIRT1 prevents atherosclerosis via liver-X-receptor and NF-κB signaling in a U937 cell model Mol. Med. Rep. 8 2013 23 28
8. L. Qiang, H.V. Lin, C.L. Kim-Muller JY,Welch, and Accili D. GuW Proatherogenic abnormalities of lipid metabolism in SirT1 transgenic mice are mediated through Creb deacetylation Cell Metab. 14 2011 758 767
9. P.1 Gao, T.T. Xu, J. Lu, L. Li, J. Xu, D.L. Hao, and et al. Overexpression of SIRT1 in vascular smooth muscle cells attenuates angiotensin II-induced vascular remodeling and hypertension in mice J. Mol. Med. Berl. 92 2014 347 357
10. T. Shen, L. Ding, Y. Ruan, W. Qin, Y. Lin, C. Xi, and et al. SIRT1 functions as an important regulator of estrogen-mediated cardiomyocyte protection in angiotensin II-induced heart hypertrophy Oxid. Med. Cell Longev. 2014 2014 713894
11. J.N. Feige, M. Lagouge, C. Canto, A. Strehle, S.M. Houten, J.C. Milne, and et al. Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation Cell Metab. 8 2008 347 358
12. J.C. Milne, P.D. Lambert, S. Schenk, D.P. Carney, J.J. Smith, D.J. Gagne, and et al. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes Nature 450 2007 712 716
13. A. Daugherty, M.W. Manning, and L.A. Cassis Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipo-protein E-deficient mice J. Clin. Investig. 105 2000 1605 1612
14. R.K. Vikramadithyan, Y. Hu, H.-L. Noh, C.P. Liang, K. Hallam, A.R. Tall, and et al. Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice J. Clin. Investig. 115 2005 2434 2443
15. R.K. Tangirala, E.M. Rubin, and W. Palinski Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor- deficient and apolipoprotein E-deficient mice J. Lipid Res. 36 1995 2320 2328
16. T. Kyaw, C. Tay, A. Khan, V. Dumouchel, A. Cao, K. To, and et al. Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis J. Immunol. 185 2010 4410 4419
17. H.L. Li, Z.G. She, T.B. Li, A.B. Wang, Q. Yang, Y.S. Wei, and et al. Overexpression of myofibrillogenesis regulator-1 aggravates cardiac hypertrophy induced by angiotensin II in mice Hypertension 49 2007 1399 1408
18. A. Purushotham, T.T. Schug, Q. Xu, S. Surapureddi, X. Guo, and X. Li Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation Cell Metab. 93 2009 27 38
19. J.N. Feige, and J. Auwerx Transcriptional targets of sirtuins in the coordination of mammalian physiology Curr. Opin. Cell Biol. 20 2008 303 309
20. Y. Nie, D.M. Erion, Z. Yuan, M. Dietrich, G.I. Shulman, T.L. Horvath, and Q. Gao STAT3 inhibition of gluconeogenesis is downregulated by SirT1 Nat. Cell Biol. 11 2009 492 500
21. F. Yeung, J.E. Hoberg, C.S. Ramsey, and et al. Modulation of NF-kappaB- dependent transcription and cell survival by the SIRT1 deacetylase EMBO J. 23 2004 2369 2380
22. Q. Li, Y. Laumonnier, T. Syrovets, and T. Simmet Plasmin triggers cytokine induction in human monocyte-derived macrophages Arterioscler. Thromb. Vasc. Biol. 27 2007 1383 1389
23. I. Mattagajasingh, C.S. Kim, A. Naqvi, and et al. SIRT1 promotes endothelium- dependent vascular relaxation by activating endothelial nitric oxide synthase Proc. Natl. Acad. Sci. U. S. A. 104 2007 14855 14860
24. P.F. Mount, B.E. Kemp, and D.A. Power Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation J. Mol. Cell Cardiol. 42 2007 271 279
25. Z. Chen, I.C. Peng, X. Cui, Y.S. Li, S. Chien, and J.Y. Shyy Shear stress, SIRT1, and vascular homeostasis Proc. Natl. Acad. Sci. U. S. A. 107 2010 10268 10273
26. M. Saura, C. Zaragoza, C. Bao, B. Herranz, M. Rodriguez-Puyol, and C.J. Lowenstein Stat3 mediates interleukin-6 [correction of interelukin-6] inhibition of human endothelial nitric-oxide synthase expression J. Biol. Chem. 281 2006 30057 30062
27. A.R. Brasier, A. Recinos, and M.S. Eledrisi Vascular inflammation and the renin-angiotensin system Arterioscler. Thromb. Vasc. Biol. 22 2002 1257 1266
28. X. Zhu, Q. Liu, M. Wang, and et al. Activation of Sirt1 by resveratrol inhibits TNF-α induced inflammation in fibroblasts PLoS One 6 2011 e27081
29. R. Gao, J. Chen, Y. Hu, Z. Li, S. Wang, S. Shetty, and J. Fu Sirt1 deletion leads to enhanced inflammation and aggravates endotoxin-induced acute kidney injury PLoS One 9 2014 e98909